We hope you find everything you need to understand how Idorsia intends to achieve its ambitious goals. If you need any further support please don't hesitate to reach out to us.

Stay informed

Idorsia offers an electronic ‘Stay informed’ service. You will get the news sent to you.

 

Events

Event When
9 Months 2018 Financial Results reporting October 23, 2018
Full-Year 2018 Financial Results reporting February 7, 2019
First Quarter 2019 Financial Results reporting April 18, 2019

Financial information

Financial information

Read all the latest financial information from Idorsia.

Our strategy

Our strategy

Find out more about the key priorities that management has set in order to develop Idorsia into one of Europe’s leading biopharmaceutical company.

Development pipeline

Development pipeline

Idorsia has a diversified clinical development pipeline in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders, and orphan diseases.

Corporate reports

Corporate reports

Find out more about Idorsia.

Contact

Contact

Andrew C. Weiss

Senior Vice President, Head of Investor Relations and Corporate Communications